Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002079210-25-000003
Filing Date
2025-12-09
Accepted
2025-12-09 08:00:09
Documents
2
Period of Report
2025-12-05

Document Format Files

Seq Description Document Type Size
1 form4-12092025_081203.html 4  
1 form4-12092025_081203.xml 4 7898
2 ex24-12092025_081203.htm EX-24 5265
  Complete submission text file 0002079210-25-000003.txt   14603
Mailing Address 500 BOYLSTON STREET SUITE 1350 BOSTON MA 02116
Business Address 500 BOYLSTON STREET SUITE 1350 BOSTON MA 02116 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

EIN.: 811591163 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VOR BIOPHARMA INC. 100 CAMBRIDGEPARK DRIVE, SUITE 101 CAMBRIDGE MA 02140
Business Address
Zuraw Qing Che (Reporting) CIK: 0002079210 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 251557662